Integrated Biopharma Inc
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supple… Read more
Integrated Biopharma Inc - Asset Resilience Ratio
Integrated Biopharma Inc (INBP) has an Asset Resilience Ratio of 0.42% as of June 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2019)
This chart shows how Integrated Biopharma Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Integrated Biopharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $84.00K | 0.42% |
| Total Liquid Assets | $84.00K | 0.42% |
Asset Resilience Insights
- Limited Liquidity: Integrated Biopharma Inc maintains only 0.42% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Integrated Biopharma Inc Industry Peers by Asset Resilience Ratio
Compare Integrated Biopharma Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
General Mills Inc
NYSE:GIS |
Packaged Foods | 2.10% |
|
Maniker F & G Co. Ltd
KQ:195500 |
Packaged Foods | 12.96% |
|
Xiwang Foodstuffs Co Ltd
SHE:000639 |
Packaged Foods | 0.18% |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716 |
Packaged Foods | -0.19% |
|
CNFC Overseas Fishery Co Ltd
SHE:000798 |
Packaged Foods | -2.62% |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895 |
Packaged Foods | 1.48% |
|
Xinjiang Chalkis Co Ltd
SHE:000972 |
Packaged Foods | 0.02% |
|
Daehan Flour Mills Co Ltd
KO:001130 |
Packaged Foods | 21.91% |
Annual Asset Resilience Ratio for Integrated Biopharma Inc (2011–2019)
The table below shows the annual Asset Resilience Ratio data for Integrated Biopharma Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-06-30 | 0.42% | $84.00K | $19.79 Million | -0.92pp |
| 2018-06-30 | 1.35% | $196.00K | $14.57 Million | -1.71pp |
| 2017-06-30 | 3.06% | $465.00K | $15.20 Million | -0.50pp |
| 2016-06-30 | 3.56% | $501.00K | $14.09 Million | -0.75pp |
| 2015-06-30 | 4.31% | $501.00K | $11.62 Million | -0.28pp |
| 2014-06-30 | 4.59% | $532.00K | $11.58 Million | -0.83pp |
| 2013-06-30 | 5.42% | $684.00K | $12.61 Million | -1.51pp |
| 2012-06-30 | 6.93% | $823.00K | $11.88 Million | +0.90pp |
| 2011-06-30 | 6.03% | $823.00K | $13.65 Million | -- |